title: Vulvar dystrophies: an evaluation.
abstract: Of 86 patients diagnosed as having vulvar dystrophy in a 10-year period 56 (65.1%) had hyperplastic dystrophy, 23 (26.7%) had lichen sclerosus and 7 (26.7%) had mixed vulvar dystrophy. The diagnoses were made by colposcopic or toluidine blue directed biopsies. Fluorinated corticosteroids were given to patients with hyperplastic dystrophy with a response rate of 90.1%. Patients with lichen sclerosus received topical testosterone propionate and the response rate was 87.7%. Topical fluorinated corticosteroids followed by testosterone propionate was given to patients with mixed dystrophy and 85.8% of the patients responded. Surgical therapy was reserved for patients with failed medical treatment.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Hacettepe, Faculty of Medicine, Ankara, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Ayhan
authors.forename: K
authors.initials: K
authors.lastname: Yüce
authors.forename: B
authors.initials: B
authors.lastname: Urman
authors.forename: A
authors.initials: A
authors.lastname: Ayhan
authors.forename: A
authors.initials: A
authors.lastname: Gököz
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005443:Flumethasone / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D013739:Testosterone / Q000627:therapeutic use; D014845:Vulvar Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
chemical_list: D013739:Testosterone; D005443:Flumethasone